| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | — | +810.0% |
| R&D Expense | $23.4M | — | +61.0% |
| SG&A Expense | $6.4M | — | +26.8% |
| Operating Income | -$26.9M | — | -39.9% |
| Pre-tax Income | -$22.7M | — | -152.7% |
| Income Tax | $317K | — | +637.2% |
| Net Income | -$23.0M | — | -153.5% |
| EPS (Basic) | -$2.21 | — | -143.2% |
| EPS (Diluted) | -$2.21 | — | -4.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.0M | +63.8% | -59.4% |
| Short-term Investments | $24.9M | -58.1% | -61.1% |
| Current Assets | $59.6M | -28.0% | -58.4% |
| Total Assets | $64.6M | -27.1% | -57.2% |
| Current Liabilities | $23.3M | +9.8% | +23.1% |
| Total Liabilities | $32.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.1M | — | -10.6% |
| Investing Cash Flow | $34.9M | — | +179.3% |
| Financing Cash Flow | -$62K | — | -100.1% |
| -4.3% |
| Stockholders' Equity | $31.8M | -40.6% | -72.7% |